The neuronal K+Cl− co-transporter 2 (Slc12a5) modulates insulin secretion
Medical Sciences
Medical Physiology
Biochemistry
Gene
Mice
Endocrinology
Diabetes mellitus
KATP Channels
Insulin-Secreting Cells
Insulin Secretion
Endocrine system
Medicine and Health Sciences
Insulin
Internal medicine
Neurons
0303 health sciences
Symporters
Q
R
Life Sciences
Medical Cell Biology
Pyridazines
Chemistry
Enteroendocrine cell
K Cl- Cotransporters
Glibenclamide
Medicine
Islet
Cell biology
Science
Pancreatic islets
Molecular Mechanisms of Aquaporins in Physiology and Disease
Transporter
Article
Cell Line
03 medical and health sciences
Biochemistry, Genetics and Molecular Biology
Sulfonylurea receptor
Health Sciences
Animals
Humans
Amino Acid Sequence
Pancreatic Islet Dysfunction and Regeneration
Molecular Biology
Biology
Secretion
Base Sequence
Endocrine and Autonomic Systems
Neurosciences
Neuron
Glucagon
Hormone
Intracellular
Alternative Splicing
Thiazoles
Glucose
Medical Neurobiology
Calcium
Surgery
Neuroendocrine Regulation of Appetite and Body Weight
Physiological Processes
Neuroscience
DOI:
10.1038/s41598-017-01814-0
Publication Date:
2017-05-04T17:43:54Z
AUTHORS (9)
ABSTRACT
AbstractIntracellular chloride concentration ([Cl−]i) in pancreatic β-cells is kept above electrochemical equilibrium due to the predominant functional presence of Cl− loaders such as the Na+K+2Cl− co-transporter 1 (Slc12a2) over Cl−extruders of unidentified nature. Using molecular cloning, RT-PCR, Western blotting, immunolocalization and in vitro functional assays, we establish that the “neuron-specific” K+Cl− co-transporter 2 (KCC2, Slc12a5) is expressed in several endocrine cells of the pancreatic islet, including glucagon secreting α-cells, but particularly in insulin-secreting β-cells, where we provide evidence for its role in the insulin secretory response. Three KCC2 splice variants were identified: the formerly described KCC2a and KCC2b along with a novel one lacking exon 25 (KCC2a-S25). This new variant is undetectable in brain or spinal cord, the only and most abundant known sources of KCC2. Inhibition of KCC2 activity in clonal MIN6 β-cells increases basal and glucose-stimulated insulin secretion and Ca2+ uptake in the presence of glibenclamide, an inhibitor of the ATP-dependent potassium (KATP)-channels, thus suggesting a possible mechanism underlying KCC2-dependent insulin release. We propose that the long-time considered “neuron-specific” KCC2 co-transporter is expressed in pancreatic islet β-cells where it modulates Ca2+-dependent insulin secretion.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (87)
CITATIONS (30)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....